It should come as little surprise that the novel coronavirus outbreak has led to the disruption - to one extent or another - of countless industries. However, some may be surprised to learn that one such sector is the pharmaceutical industry and, more specifically, the global supply chain it relies on to conduct business on an ongoing basis.
Assistant Professor of Public Policy Soroush Saghafian, whose academic interests include applying operations research methods to health care management, has been working with the government of Bahrain to analyze the effectiveness of policies to address the coronavirus. Saghafian, who is a faculty affiliate of the Harvard PhD program in health policy and the Harvard Center for Health Decision Science, cautions that no one policy is best in all cases—and that governments must weigh cost and quality of life considerations. However, he says that closing businesses like cinemas and gyms for four months could be one of the most low-cost and effective measures. Saghafian shared analysis that he and his former PhD student (now an assistant professor of statistics and family medicine at Michigan State University) Alireza Boloori conducted in an HKS faculty working paper, “COVID-19: What Intervention Policies Are Most Effective? A Brief Report Using Data from Government of Bahrain.”
David Simchi-Levi, professor of engineering systems at MIT, talks about what’s next for supply chains, as the U.S. looks to reopen businesses after the coronavirus quarantine.
Now that Gov. Phil Murphy has reopened the Jersey Shore for the Memorial Day holiday, will the crowds come? Experts and a poll said people are more likely to drive to the beach at Belmar than fly to French riviera. Another temptation to get them out of the house are lower than normal gas prices. But it will be a gradual transition from coronavirus staycation to vacation.
The world was waiting for any sign of hope in countering the COVID-19 pandemic when researchers released the first encouraging drips of data from a large clinical trial of the antiviral remdesivir last month. The drug, they said, reduced the time to recovery from COVID-19 by a few days — not enough to be branded a ‘cure’, but hopefully enough to relieve some pressure on overwhelmed health-care systems.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
Catastrophic weather events, wars in Ukraine and the Middle East, trade conflicts, global pandemics—the forces disrupting supply chains are multiplying at a rate few could have anticipated.
A hat and sunglasses may not be enough to fool the most sophisticated facial recognition algorithms.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
During the holiday season, a late delivery can sometimes feel like the end of the world. You’ve been there: you order a highly anticipated gadget, new clothes, or a last-minute gift, only to find out that your delivery is delayed. While many blame shipping companies or delivery drivers, the true culprit often lies deeper in the supply chain — at the heart of it all: forecasting.
Catastrophic weather events, wars in Ukraine and the Middle East, trade conflicts, global pandemics—the forces disrupting supply chains are multiplying at a rate few could have anticipated.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.